Oral pentobarbital suspension for children sedation during MR imaging.

Ann Pharm Fr

Service pharmacie clinique, hôpital Jean-Verdier, hôpitaux universitaires de Paris-Seine-Saint-Denis, Bondy, France.

Published: July 2018

Objectives: The efficacy and safety of an oral pentobarbital suspension for sedation during pediatric MR imaging were assessed.

Methods: Data were recorded from October 2016 to January 2017. The exact dose of oral pentobarbital suspension was given for each child with an oral syringe. Parameters recorded included the patient's age and weight, the time required to sedate, the duration of sedation, the time required to discharge, and quality of MR imaging. The adverse effects were recorded.

Results: Oral pentobarbital suspension was administered to 81 children aged from 8 months to 8 years at a dose of 5mg/kg of body weight. The mean time required to sedate was 30±21min, a mean time of sedation of 47±23min, and a mean time to discharge of 77±32min. Sedation occurred a satisfied quality of MR imaging in 67% of patients. The failure of examination was essentially due to bad taste of the drug suspension. The overall success rate of sedation in patients less than 12 months was 100%. For ages 1 to 3 years, the success rate decreased to 76% and for ages 4 to 8 years, it decreased to 42%.

Conclusions: Oral pentobarbital suspension used in MR imaging demonstrated its high rate of successful sedation in infants less than 12 months with no adverse effects during the study period.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharma.2018.03.002DOI Listing

Publication Analysis

Top Keywords

oral pentobarbital
20
pentobarbital suspension
20
time required
12
weight time
8
required sedate
8
quality imaging
8
adverse effects
8
success rate
8
ages years
8
sedation
7

Similar Publications

Background: Sedation is often required for pediatric medical imaging procedures to ensure compliance and image quality. Recommendations for pediatric sedation exist, but there are currently no guidelines for the choice of the sedative drug.

Objective: To compare the efficacy and adverse events of per os pentobarbital with intravenous chlorpromazine in children undergoing diagnostic imaging procedures.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is a chronic skin disease linked to an abnormal immune reaction and oxidative stress, which can worsen due to sleep disturbances.
  • The Xiaoyin-Anshen formula (XYAS), a traditional Chinese medicine, shows promise in treating psoriasis, especially for patients suffering from sleep issues, but its exact effects are not fully understood.
  • A study using a mouse model aimed to investigate how XYAS influences melatonin levels, reduces oxidative stress, and mitigates psoriasis-like inflammation through a series of treatments and tests.
View Article and Find Full Text PDF
Article Synopsis
  • "Endod" (L' Herit) is a traditional Ethiopian medicinal plant known for its use as a detergent, which has now been studied for its ability to protect against liver damage induced by acetaminophen (APAP) in rats.
  • The study involved administering different doses of Endod's methanol root extract to evaluate its hepatoprotective effects on liver enzymes, bilirubin levels, and lipid profiles after APAP-induced liver injury.
  • Results showed that the plant extract significantly improved liver function and offered protective benefits, with confirmed results from both biochemical analyses and histopathological examinations.
View Article and Find Full Text PDF

We investigated the effects of L. extracts (Lactuc) on pentobarbital-induced sleep in mice to elucidate the mechanisms underlying its impact on sleep quality. Mice were randomly assigned to five groups: control, positive control (diazepam 2 mg/kg b.

View Article and Find Full Text PDF

Objective: To assess the efficacy of transmucosal euthanasia solution to induce euthanasia.

Animals: 6 bearded dragons (Pogona vitticeps).

Methods: An initial dose of euthanasia solution containing pentobarbital and phenytoin sodium was administered transmucosally in conscious lizards (100 mg/kg pentobarbital dose), followed by a second dose 20 minutes later (400 mg/kg pentobarbital dose).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!